Evercore ISI Group Maintains Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $88
Crinetics Pharmaceuticals Inc CRNX
$36.27
▲ +3.81%
(+$1.33)
Open
$35.24
Prev Close
$34.94
Day Range
$35.23 – $36.55
52W Range
$25.83 – $57.99
Market Cap
$3.82B
Beta
0.26
EPS (TTM)
$-5.13
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-07-18 |
| Shares Out. | 105,440,000 |
| Website | crinetics.com/ ↗ |
| Phone | 18584506464 |
Crinetics Pharmaceuticals Inc is a publicly traded company under the ticker symbol CRNX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
22 analysts (2026-05-01)
📰 Latest News for CRNX
Crinetics Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
Twilio To Rally Over 25%? Here Are 10 Top Analyst Forecasts For Monday
Oppenheimer Maintains Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $84
Citizens Maintains Market Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $95
Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2026 Earnings Call Transcript
Transcript : Crinetics Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 07, 2026
Crinetics Pharmaceuticals (NASDAQ:CRNX) Beats Q1 Expectations on Strong PALSONIFY Launch, Stock Slips After Hours